This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Fish & Richardson is pleased to announce that the firm has been named a “Law Firm of the Year” for Litigation – Intellectual Property and Litigation – Patent in U.S. News & World Report – Best Lawyers “Best Law Firms” 2023 edition. Litigation – Intellectual Property . PatentLaw .
by Dennis Crouch The Supreme Court is set to consider several significant patentlaw petitions addressing a range of issues from the application of obviousness standards, challenges to PTAB procedures, interpretation of joinder time limits IPR, to the proper scope patent eligibility doctrine. Mangrove Partners Master Fund (No.
On June 1, 2021, the Fourth Amendment to the Chinese PatentLaw became effective. An important part of the amendment is the introduction by Article 76 of the patent linkage system in China – a system for litigation of drug patents prior to market entry of generics, similar to that provided by the Hatch Waxman Act in the US.
24, 2023) (Shashi H. Kewalramani), the Central District of California denied Defendant Netflix’s attempts to compel Plaintiff GoTV Streaming to provide documents and further information as to the source of the litigation funding that GoTV received in conjunction with the patentlitigation. Netflix, Inc.,
Brussels Court of Appeal, 30 January 2023, Biogen v. Mylan In this typical preliminary injunction (PI) case, the Brussels Court of Appeal seems to have refined its case-law. Brussels Court of Appeal, 13 February 2023, Merck Sharp & Dohme v. Is the wind shifting. ? The dispute arose between Biogen and Mylan.
In the Hatch-Waxman arena of patentlitigation, the crisscross of patentlaws and FDA regulations is always in play. Avadel CNS Pharmaceuticals, LLC, 2023 WL 2198640 (Fed. 24, 2023), we see another iteration of this with respect to listing a method-of-use patent in the Orange Book.
These were clearly watershed cases that dramatically changed the landscape of patentlaw and patentlitigation. 2023) , highlights the current state of the law. Since 2012, almost 2,000 court decisions have referenced these cases along with 8,000+ PTAB decisions. The recent decision in Hawk Tech Sys.
Patent and Trademark Office (PTO) are constantly reshaping patentlaw, and this program will teach you everything you need to know about the basics of patentlitigation in this dynamic, rapidly changing landscape. Whether you’re a novice or experienced patentlitigator, By: Practising Law Institute (PLI)
The past several years have brought a dizzying array of changes in patentlaw, between proposed new legislation, new USPTO filing procedures, and Supreme Court activity at a rate not seen in decades. By: Practising Law Institute (PLI)
As 2023 commences, it’s time for companies to review and take stock of their intellectual property assets. Such inventions may be protectable under federal patentlaws. An inventor must secure a patent application within a very short period of time to prevent the work from falling into the public domain.
(October 5-November 23) Following a favorable outcome of preparing students and professionals for the patent agent exam and providing them with a comprehensive guide on Patents in 2022 and 2023. The IP Press presents the third cohort of the Comprehensive Course on Patents. Majumdar & Co.,
We recently came across one such short paper on “ SEP Litigations & Issues in Determining the FRAND License ” published in the September 2023 issue of the Journal of Intellectual Property Rights (see here ) and extended a guest post invitation to its authors to discuss their key arguments.
Although a patent can be challenged in federal district court, an IPR is an expedited and less costly procedure than federal court litigation. Thus, an IPR is a useful method for a defendant in a patentlitigation lawsuit to invalidate the patent in issue. In Apple v.
On June 1, 2021, the Fourth Amendment to the Chinese PatentLaw became effective. An important part of the amendment is the introduction by Article 76 of the patent linkage system in China – a system for litigation of drug patents prior to market entry of generics, similar to that provided by the Hatch Waxman Act in the US.
The Seventh Circuit issued this week a long-awaited opinion in the HUMIRA antitrust litigation, UFCW Local 1500 Welfare Fund v. “The patentlaws do not set a cap on the number of patents any one person can hold—in general, or pertaining to a single subject.” market until 2023.” AbbVie Inc.
While the AmeriKat is still recovering from 2020, her Belgian Katfriends sum-up what was 2022 in Belgian patentlitigation 'Tis the season for a look at the cases that were in 2022 from around Europe and what they mean for the IP litigation themes in those jurisdictions now that the dust has settled in 2023.
So, we dive into the dispute over the role of scientific advisers versus expert evidence in IP litigation. In a recent c a se , the English Patent Court dealt with the distinction between scientific advisers and expert evidence offering an intriguing insight into the matter. A little bit about the Indian paradigm.
Udupa has been working in patents since she graduated from American Univ Law in 2000: First at Pennie & Edmonds before its breakup; then at Jones Day for a decade as a patentlitigator; and finally at Hewlett Packard for the past decade as Associate General Counsel for litigation. It is a 5-year appointment.
On December 4, 2023, the Court of Appeals for the Federal Circuit vacated a $2.18 The Federal Circuit then remanded the case back to the district court for further proceedings consistent with its opinion.
In addition, HIP argued that the ruling would have an adverse impact on patentlaw because “business decisions based on patent assignments may now be called into question based on the allegation that the quantity of a joint inventor’s contribution was too small.” On November 6, 2023, the U.S.
Merpel does not like this form of taxi Friend of the Kat and Legal Head of Delivery for Gett in Moscow, Konstantin Voropaev has been following some developments out of Kazakhstan relating to an uptick in litigation in the taxi-app space. The patent is valid until 21 December 2023. So what is going on?
Even some judges on the Federal Circuit have labeled the eligibility framework as an “incoherent doctrine” [1] that might tempt district courts into “an effective coin toss,” [2] while others have openly confessed that “the nation’s lone patent court … [is] at a loss as to how to uniformly apply § 101.” [3]
At the close of 2023, the Supreme Court of the United Kingdom handed down its eagerly awaited and widely publicized judgment in Thaler v Comptroller-General confirming that a patent application may not name an AI machine as an inventor. So for those beloved folks, this article in Cycling Weekly will really hit the spot.
The IPO has a history of prioritising public health, as seen when it rejected a patent ( pdf ) for the salt form of Bedaquiline, an essential drug for drug-resistant tuberculosis, in 2023. The PGO system in Indian patentlaw allows anyone to contest a patent before it’s granted, ensuring that only genuine innovations make it through.
The article shows the growing prevalence of double patenting, with terminal disclaimers now being filed for over 15% of all patents, over 50% of litigatedpatents, and 60% of Orange Book patents covering FDA-approved drugs. This report aligns with my data shown in the chart above for all utility patents.
Proper venue is rarely a big deal these days in Federal Litigation. But, patentlaw is different. In the late 1800s Congress created a special venue statute for patent cases that has stuck despite changes in the general law. Trial is set for May 12, 2023. 22-cv-00320; 20-cv-00876.
Late last week, more than half a dozen amicus briefs were filed in support of GM Global Technology Operations in a case that is set to potentially shake up design patentlaw. Court of Appeals for the Federal Circuit (CAFC) to keep the law as is in order to avoid major disruptions.
The Comparative Analysis section almost exclusively focuses on patent practices of developed countries. Conversely, it is more important that the most impactful patent applications are strictly scrutinised and efficiency achieved on this front. For instance, the Dhaval Diyora case which was litigated in Bombay High Court and Ms.
AI Kat A critical question in European patentlaw is therefore the evidence and disclosure requirement for a purported technical effect. However, there is currently a dearth of Board of Appeal case law relating to the evidence requirement for machine learning inventions. G 2/21 and its interpretation: Beyond biotech?
Nu Tsai Capital, LLC, [2023-1146] (February 17, 2023), the Federal Circuit vacated a preliminary injunction against Lite-Netics patent-related speech, holding that the district court abused its discretion. 6 for filing the most patent applications on behalf of those companies. In Lite-Netics, LLC v.
It turns out AI has incredible potential to serve as a primary guardian of patents. A Decade of Decline in PatentLitigationPatentlitigation has been declining in the United States, with the number of new patent lawsuits in 2023 dropping 24% from 2022.
IPRs and PGRs were created by the Leahy-Smith America Invents Act as a more efficient and effective means for challenging the validity of patents and are also intended to reduce litigation costs. 315(b) (contemplating the relationship between IPRs and coexisting district court infringement litigation). Intri-Plex Techs.,
In patentlaw, inventorship is tied directly to ownership. An inventor is a presumptive owner of any resulting patent rights. 21-CV-1450, 2023 WL 362504, at *16 (S.D. 23, 2023). Read the Decision: [link] Note: I don’t think that the napkin is of record yet in the litigation. Teleport Mobility, Inc. ,
12, 2023) (per curiam), the Patent Trial and Appeal Board (the “Board”) found that petitioner Ventex Co., In response, Ventex argued that it put proper litigation holds in place starting in May 2017 and voluntarily produced documents in October 2018 that were not covered by Columbia’s requests and therefore did not conceal evidence.
Six Founders Legal® Attorneys Named to 2024 Best Lawyers: Ones to Watch® in America by Founders Legal Distinguished Achievements in Intellectual Property, PatentLaw, Technology, Corporate Governance and Compliance, and Mergers & Acquisitions Law. ” Yuri L. Eliezer and Andrei D.
Fish & Richardson is proud to announce the elevation of 15 attorneys to principals at the firm, effective January 1, 2023. With deep expertise in litigation and patent prosecution and counseling, the attorneys represent clients across a range of industries and in various legal venues. Joel Henry (Washington, D.C.),
FOR IMMEDIATE RELEASE October 25, 2023 Champaign, Illinois – Julie King, King Business and PatentLaw, PLLC, Champaign, Illinois was recently named to the National Small Business Association (NSBA) Leadership Council. ” King founded King Business and PatentLaw in 2017. .
This tome was first published in 1884 by Thomas Terrell, and in the 140 years since, has become a well-established authority for patent practitioners and judges, providing thorough commentary on both the substance and practice of UK patentlaw. pesticides). It is here that the effect of Brexit is most noticeable.
by Dennis Crouch The Federal Circuit’s new Finjan decision once again focuses attention on what I call patentlaw’s “ indefinite article shuffle.” The Federal Circuit issued a similar opinion earlier in 2023 in Salazar v. ” Finjan v. SonicWall — F.4th 4th — (Fed. 4th 1311 (Fed.
30, 2024) (R&R) Recommendation: Dastar should block Qingdao’s Lanham Act false advertising counterclaims based on Lashify’s claim to be the originator of lash technology, but false patent marking counterclaims should survive. 11, 2023 (claiming that various products were “patented”). patentlaw. 1, 2017 to Apr.
by Dennis Crouch The law of appellate jurisdiction routes almost every patent appeal to the Court of Appeals for the Federal Circuit. patentlaws. 1, 2023) provides an exception to the general rule. This result is by design to ensure more national uniformity in application of the U.S. SAP SE , 22-1286 (Fed.
By Sarah Burstein, Professor of Law at Suffolk University Law School LKQ Corp. 2023) ( docket ). As Professor Crouch has noted , the Federal Circuit has granted rehearing en banc in the design patent case of LKQ v. Not to mention the significant litigation and uncertainty costs such an approach would entail.
Vanda Pharmaceuticals recently filed a petition for writ of certiorari , asking the Supreme Court to review a May 2023 decision by the Federal Circuit that invalidated claims from four Vanda patents covering methods of treating Non-24-Hour Sleep-Wake Disorder (“Non-24”) using the drug tasimelteon (Hetlioz).
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content